EPO and non-small cell lung carcinoma: First, some reports have suggested that chronic inflammation plays a significant role in the development and progression of NSCLC, and inflammatory cells release various signaling molecules, which may affect the synthesis or activity of erythropoietin, thus impairing red blood cell maturation and causing immature red blood cells to enter the blood flow28.